CL
ChemoMouthpiece, LLC
SEC filingOther Health Care · Wilmington, DE
Amount raised$400Ksold at filing
Total offering$10M$9.6M still open
Investors in the raise3count reported to the SEC
FiledOct 30, 2026first sale Oct 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David YoskowitzExecutive Officer
Frank ArdizzoneExecutive Officer
Jeffrey SchwabDirector
Shlomo LehrmanDirector
Executive officers, directors and promoters as listed on the Form D.